Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Effectiveness of Neuro-Feedback on the Severity of Gastrointestinal Symptoms, Depression, Anxiety, Stress and Quality of Life in Patients With Irritable Bowel Syndrome (Ibs): A Randomized Controlled Clinical Trial; [اثزبخشی نوروفیذبک بز شذت علائم گوارشی، افسزدگی، اضطزاب، استزس و کیفیت سنذگی بیماران مبتلا به سنذرم روده ی تحزیک پذیز: یک کارآسمایی بالینی تصادفی با گزوه گواه] Publisher



Ebrahimi A1 ; Dehsorkhi SN2 ; Daghaghzadeh H3 ; Dehsorkhi HN4, 5 ; Sadrameli S2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Health Psychology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Soroush Andisheh Ebn e Sina Clinical Psychology Institute, Isfahan, Iran
  3. 3. Gastroenterology and Liver Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  4. 4. Gastroenterology and Hepatology Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  5. 5. Department of Clinical Psychology, Roudehen Branch, Islamic Azad University, Roudehen, Iran

Source: Journal of Isfahan Medical School Published:2023


Abstract

Background: New technologies in neuroscience like neurofeedback (NFB) is one of the growing and challenging issues. The aim of present study was to determine the effectiveness of NFB on the severity of gastrointestinal (GI) symptoms, depression, anxiety, stress and quality of life in irritable bowel syndrome (IBS) patients. Methods: This study was a double-blind clinical trial with a control group conducted in 2021 .The Initial screening included 160 patients with IBS who were referred by a gastroenterologist. Thirty patients were randomly assigned to three groups of NFB intervention; placebo (Pseudo-NFD) and control group (GI drugs only). The groups completed the IBS Severity Scale (IBS-SSS), Depression, Anxiety and Stress Scale (DASS-42) and IBS Quality of Life Questionnaire (QOL-IBS) before and after the intervention. Data were analyzed using ANOVA. Findings: The results showed that NFB and placebo had a greater and significant effect on reducing depressive symptoms and IBS severity compared to the drug alone (P < 0.05). The placebo group with the drug showed an increase in higher quality of life scores than the other groups (P < 0.05). There was no significant difference between the groups in stress and anxiety. Conclusion: The findings support the use of NFB along with medication for IBS patients, which is associated with appropriate therapeutic relationship, to enhance the effectiveness of interdisciplinary interventions. © 2023 Isfahan University of Medical Sciences(IUMS). All rights reserved.
2. Nocebo and Psychological Factors in Irritable Bowel Syndrome: A Scoping Review, International Journal of Body, Mind and Culture (2022)
Experts (# of related papers)
Other Related Docs
26. Small Fiber Neuropathy in Irritable Bowel Syndrome, Gastroenterology and Hepatology from Bed to Bench (2024)
40. Relationship Between Depression and Constipation: Results From a Large Cross-Sectional Study in Adults, The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi (2022)
43. Psychological Issues in Inflammatory Bowel Disease: An Overview, Gastroenterology Research and Practice (2012)